3-2736310-G-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_175607.3(CNTN4):c.151G>C(p.Glu51Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000616 in 1,461,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175607.3 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: ClinGen
- autism spectrum disorderInheritance: AD Classification: NO_KNOWN Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461532Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727078 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.151G>C (p.E51Q) alteration is located in exon 4 (coding exon 2) of the CNTN4 gene. This alteration results from a G to C substitution at nucleotide position 151, causing the glutamic acid (E) at amino acid position 51 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at